The long-term effect of specific type II 5α-reductase inhibition with finasteride on bone mineral density in men: Results of a 4-year placebo controlled trialMATSUMOTO, Alvin M; TENOVER, Lisa; ZHANG, Gang K et al.The Journal of urology. 2002, Vol 167, Num 5, pp 2105-2108, issn 0022-5347Article

Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasiaWESSELLS, Hunter; ROY, Johnny; PARRA, Raul et al.Urology (Ridgewood, NJ). 2003, Vol 61, Num 3, pp 579-584, issn 0090-4295, 6 p.Article